nized in the scientific community. Even if the contaminating cells have only a slight growth advantage, the intruding cells will overgrow and completely replace the original cell line, sooner or later. The most notorious culprit of such cross-contamination is, of course, the infamous solid tumor cell line HeLa.
The two biggest problems in cell line culture
The two biggest problems in cell culture of continuous cell lines involve contaminations: 1 • contamination with microorganisms, in particular with mycoplasmas;
• cross-contamination with other cell lines.
At the cell line bank of the DSMZ-German Collection of Microorganisms and Cell Cultures, we have found that about 30% of the cell lines received were infected with mycoplasmas.
2 Even more disturbing is the high percentage of cell cross-contamination, a problem that is not sufficiently recogCorrespondence: HG Drexler; Fax +49-531-2616.150 Received 30 April 1999; accepted 1 June 1999 nized in the scientific community. Even if the contaminating cells have only a slight growth advantage, the intruding cells will overgrow and completely replace the original cell line, sooner or later. The most notorious culprit of such cross-contamination is, of course, the infamous solid tumor cell line HeLa. 3 The history of cell cross-contamination in cell cultures is long and painful; the first report on cell line cross-contamination appeared in 1957. [4] [5] [6] [7] [8] [9] The advent of forensic DNA profiling and its application to cell line identity testing now permits the detection and identification of cell line crosscontamination with levels of sensitivity and accuracy greatly surpassing those achievable in classical surveys. The salient aspects of this common cell culture problem have been highlighted in a recent review. 9 It has been estimated that more than one-third (!) of cell cultures in use are cross-contaminated either with cells from other species (interspecies contamination) or with unrelated cells from the same species (intraspecies contamination). 9 Such cell cultures may be grown, maintained, and used for years, and results may be published without documented authenticity of the cells. The potential problems and even dangers in using cross-contaminated cell cultures for the quality of research and production in virtually any scientific or biomedical area cannot be overemphasized (invalid research results, financial loss, bodily harm, etc).
Our cell line bank experience shows that in a recent series from 1990 to 1998 a large percentage of allegedly new human cell lines (cell lines derived from solid tumors and hematopoietic malignancies) which were received from the original investigators (in contrast to cell cultures obtained from secondary sources) were cross-contaminated with other cell lines: 10 • 45/252 (18%) human cell lines were false; • 27/93 (29%) original donors supplied false cell lines.
High incidence of cross-contaminated cell lines
Our data on cross-contaminated cell lines quoted above are, presumably, only the tip of the iceberg: as pointed out, these findings refer to cell lines which were received from the original investigators. Commonly, cell lines are passed from laboratory to laboratory and here the percentages of false cell lines are definitely higher. While undoubtedly the majority of cases go unnoticed or are occasionally detected and then silently corrected, the frequency of intra-and interspecies contamination events can be surmised from several publications that offer résumés of experiences with cultures submitted specifically for monitoring and excluding crosscontamination.
Nelson-Rees et al [5] [6] [7] 11 found that 41/253 (16%) cell cultures from 45 laboratories were not as they were purported to be; cultures were sent for routine monitoring or because the cultures were suspected of being contaminated. In another series, Nelson-Rees and co-workers 12 reported that 16% of cell lines obtained from 466 laboratories were incorrectly identified. Stulberg and colleagues 13 examined 246 cell lines for evidence of cross-contamination or mislabeling. They reported a frequency of 14% for interspecies contamination and 25% for intraspecies contamination; overall nearly 30% of the cell lines were incorrectly designated. Hukku et al 14 summarized data from 275 cultures sent to their laboratory for analysis of cross-contamination. They found that overall 35% of the cultures received were contaminated; 36% of the human cell lines were cross-contaminated (25% by cells of another species and 11% by another human cell line).
The preferential inclusion of suspect cell cultures may have caused a certain bias leading to a slight overestimation of the problem in these studies. Nevertheless, the prevalence of cross-contaminated human cell lines is certainly in the range of 10-30% and is clearly a major concern.
Methods for cell line authentication

Isoenzyme analysis
A traditional method is isoenzyme analysis, taking advantage of the different banding patterns and relative migration distances for the individual isoforms of intracellular enzymes with similar substrate specificity, but different molecular structures (such as lactate dehydrogenase, purine nucleoside phosphorylase, glucose-6-phosphate dehydrogenase, malate dehydrogenase and others) in agarose gel electrophoresis. 1, 15 This technique can be used for interspecies contamination which should be detectable if the contaminating cells represent at least 10% of the total cell population. 16 
DNA fingerprinting
The technique of DNA fingerprinting has great potential for the authentication of cell cultures and identification of crosscontamination. Each individual's DNA gives specific banding patterns with exclusion rates of 99.99% or higher. Various single-locus and multi-locus probes can be used (for reviews see . A polymerase chain reaction-based minisatellite typing assay in a multiplex format has been recently designed. 20, 21 DNA fingerprinting was introduced in 1985 22 and was first applied for identification of cell line cross-contamination in 1988. 23 Since then, DNA fingerprinting has become the methodology used most often for determination of cell line authenticity. [24] [25] [26] [27] The detection level varies depending on the technique and probes used and is in the range of 5-30% contaminating cells. Of utmost importance for cell line banks is the development of a library of fingerprints stored in modern searchable database systems. 21 
Cytogenetic analysis (karyotyping)
Chromosome analysis is currently considered the most sensitive standard method for identification of intraspecies contamination. Although routinely lower sensitivity can be achieved, an experienced cytogeneticist may detect a contamination of 1%.
9,10,28 However, chromosome analysis is a labor-intensive, time-consuming and rather expensive procedure; interpretation may require a high degree of skill. Still, cytogenetics without question is the method currently offering the highest versatility in the characterization of a cell line (not only specifically for the purpose of identification/ authentication). 28 DNA fingerprinting and cytogenetic analysis have their advantages and disadvantages, but they complement rather than exclude each other. 1 The DNA profiling technology appears to be destined to become the method of choice for routine authentication.
Cross-contamination of hematopoietic cell lines
The problem of false cell lines did, of course, not spare hematological research where leukemia-, lymphoma-and myeloma-derived cell lines are extremely important research tools. The first case of a false hematopoietic cell line is J-111 published in 1955 as an 'acute monocytic leukemia cell line'. 29 In 1976, J-111 was unequivocally 'outed' in the journal Science as a derivative of the cervix carcinoma cell line HeLa. 6 Still, a literature search shows that alone in the 1990s (as recently as 1998) there are more than a dozen publications using J-111 as a cell line model for 'monocytes, histiocytes or monocytic leukemia'. However, the morphology of the J-111 cells in culture is that of a (strongly adherent, epithelial-like) solid tumor cell line and totally different from commonly used monocytic reference cell lines, eg THP-1 and U-937, or any other hematopoietic cell line we have ever seen. 30 The initially inadvertent cross-contamination of human Hodgkin's disease-derived cell cultures with monkey cells (cell lines FQ, RB and SpR) and the subsequent deliberate fraud using these cell lines caused a scandal in 1980: this case was reported in the journals Science 31 and Nature 4 and in the New York Times, led to a hearing before a subcommittee of the US Congress, and also found its entry into the book Betrayers of the Truth: Fraud and Deceit in Science. 32 From 1990-1999, the DSMZ Cell Line Bank received 189 cell cultures representing 170 human hematopoietic cell lines (in 19 cases, cells from the supposedly same cell line were obtained a second or third time from independent sources): 117 cell lines came from the original investigators and 72 from secondary sources. Using a combination of DNA fingerprinting and cytogenetic analysis (representative examples are shown in Figures 1 and 2) , we found that 17/117 (14.5%) cell lines from the original source and 11/72 (15.3%) cell lines from a secondary source were cross-contaminated with another hematopoietic cell line (total: 28/189 = 14.8%). Table 1 lists the hematopoietic cell lines which were crosscontaminated at the original source and for which it is known that no correct culture under that name exists any longer. Table 2 shows the contaminated cultures which we encountered in our study and which masquerade under the pseudonym of another existing cell line; in these cases, the bona fide correct cell lines with their proper designations do still exist. These two lists in Tables 1 and 2 are not all-inclusive as we have tested only about 15% of the more than 1000 human malignant hematopoietic cell lines described in the literature. 66 Often the results of cytogenetic analysis and of DNA fingerprinting showing similar marker chromosomes and identical banding patterns, respectively, for two allegedly individual cell lines are questioned on the basis that the two cell lines are phenotypically and functionally quite different (particularly in cases where the cell lines are supposed to be Single locus (AmpFLP VNTR minisatellite) and multilocus (STR microsatellites) DNA fingerprint profiles of NALM-6 and derivatives: One ng to 100 ng of genomic DNA of the cell lines indicated were used to amplify alleles from the human VNTR markers Apo-B, D17S5, D1S80 and D2S44 employing PCR (upper part). After size determination of the amplicons from each locus on a separate gel, the data were entered in a database creating a specific DNA profile in order to search for uniqueness. The cell line HeLa was included as a control. For further confirmation of cell line identity a high resolution fingerprint using STR microsatellites was carried out (lower part). Ten microgram of DNA isolated from cell lines with identical AmpFLP VNTR patters were digested to completion with HinfI, size-separated on agarose gel and blotted on a membrane. After hybridization with (GTG) 5 , the blot was exposed for 2 h to X-ray films. A detailed description of the methods employed is given elsewhere. 20, 21 Note that the three allegedly individual and unique cell lines, NALM-6, PBEI and LR10.6, 33 show identical fingerprinting patterns in both the minisatellite and microsatellite fingerprinting (the exclusion rate is Ͼ99.9%); thus, all three cultures are in reality NALM-6. M, marker; AmpFLP, amplified fragment length polymorphism; PCR, polymerase chain reaction; STR, short tandem repeats; VNTR, variable number of tandem repeats.
derived from the same type of disease or belong to the same cell lineage). 43 It is, no doubt, true that different bona fide subclones of a given cell line may perform in different ways and exhibit many distinct characteristics. Nevertheless, cell lines commonly retain their cytogenetic marker chromosomes and the DNA fingerprint pattern, in spite of different passage Presence of unique chromosome rearrangement betraying cross-contamination: Image depicts metaphase chromosomes (blue) from the false cell line SPI-802 which is derived from CML cell line K-562. Cells carry two marker chromosomes (yellow arrows) comprised of repeats of BCR (green) and ABL (red) oncogenes fused in tandem (overlapping signals staining yellow) to form homogeneously staining regions (hsr). Unrearranged copies of BCR (green arrow) and ABL (red arrow) are also present. Inset shows detailed composition of one hsr from a prometaphase cell displaying apparent 10-fold amplification. Only one cell line, K-562, has been reported with this alteration hitherto. [34] [35] [36] K-562 was established in 1970 37 and has been widely distributed since; whereas SPI-802 was first reported more than 10 years later. 38 Conventional karyotyping revealing the presence of a der(2;11)(q10;q10) marker chromosome as originally described additionally confirms the real identity of SPI-802. Metaphase cells were hybridized overnight with the directly labeled BCR-ABL1 S-FISH translocation probe (Oncor-Appligene, Heidelberg, Germany) and stringency washed according to the manufacturer's instructions, counterstained with DAPI and mounted in Vectashield (Camon, Wiesbaden, Germany). Preparation was viewed by epifluorescence using a Zeiss Axioscope configured to a FISH imaging system (Vysis, Stuttgart, Germany) and three separate monochromatic images (one for each color) were captured, merged and contrast-enhanced. levels under different growth conditions and in different laboratories. It is our experience that de facto morphology, immunoprofile, and functional features (and unfortunately also certain unstable microsatellite loci) are inadequate criteria for culture authentication of hematopoietic cell lines.
Non-malignant cell lines derived from patients with a hematopoietic malignancy
A cell line established from a patient with leukemia is not necessarily a 'leukemia cell line'. Early studies from the 1960s documented that Epstein-Barr virus (EBV) infection is capable of immortalizing certain B cell subsets in normal human leukocyte cultures but also in samples from patients with malignant hematopoietic cells, hence the designation 'EBV + B-lymphoblastoid cell lines (B-LCL)'; this term was adopted to define For abbreviations see legend to Table 1 . a References for the correct cell lines. b Widely used subclone allegedly derived from cell line REH (not included in our statistics as it is an interspecies cross-contamination).
this type of non-malignant lymphoid cell. 67 The biological activity of EBV lies in its capacity to transform resting B cells into immortalized lymphoblastoid cells that proliferate indefinitely and harbor the virus in a latent state. Various EBV genes are expressed as proteins in EBV + B-LCLs which divide continuously in vitro as a result of the expression of these genes. It appears to be 10-to 100-fold easier to establish an EBV + B-LCL from a patient with leukemia than a neoplastic leukemia cell line. 68 The clear distinction between a malignant hematopoietic cell line and an EBV + B-LCL is particularly relevant for cell lines established from patients with mature B cell malignancies such as chronic lymphocytic leukemias, hairy cell leukemia, B cell non-Hodgkin's lymphomas, myeloma and other malignancies. The issue is further complicated by the fact that all EBV + B-LCLs will eventually become monoclonal, aneuploid, grow as colonies and form tumors in nude mice. 68 Still, in most cases 'true malignant hematopoietic cell lines' can be discerned from EBV + B-LCL by different parameters (see below).
A striking example can be found in the case of some putative 'myeloma cell lines': there are various EBV + B-LCLs which are often used as model systems in myeloma research. Some of these cell lines are listed in Table 3 ; this list should not be considered to be exhaustive as there are presumably many more 'misinterpreted cell lines'; the cell lines in Table 3 appear to be the most often (mis)used cell lines. The cell line HS-SULTAN, which is clearly an EBV + Burkitt lymphomaderived cell line, is also frequently employed as a 'myeloma cell line' (Table 1 ). There are several significant differences between myeloma cell lines and B-LCLs: (1) in suspension or slightly adherent, whereas EBV + B-LCLs grow in small or large clumps, and the cells display very typical polymorphic extensions; (3) our experience from karyotyping more than 100 leukemia-lymphoma-myeloma cell lines together with data from the literature indicate that out of 600 true malignant hematopoietic cell lines less than 0.5% have a normal karyotype without any structural or numerical chromosomal aberrations; on the contrary, for example the B-LCL IM-9 does not carry any numerical or structural alterations at all, but has a normal diploid karyotype; 1 (4) the immunoprofiles of, for instance, the B-LCLs ARH-77, IM-9 and MC/CAR, are clearly discordant from those of true myeloma cell lines. 70 In summary, the interpretation of non-malignant EBV + BLCLs as representatives of the malignant in vivo clone is clearly misguided and raises some concerns regarding the conclusions drawn in studies using such cell lines. A combination of markers commonly allows for an accurate determination of the nature of the cell lines: immunoprofile, cellular morphology, EBV status, and karyotype.
Possible solutions to the problem of 'false cell lines'
Authentication of new cell lines
In order to avoid problems before they arise, namely during the establishment, propagation and dissemination of new cell lines, a rigorous authentication of any new cell line is absolutely mandatory. In other words, it must be shown unequivocally that the cultured cells are indeed derived from the presumed patient's tumor and are not the result of a crosscontamination by an older cell line. The method of choice for this identity control is DNA fingerprinting. Microsatellite analysis using only certain loci does not appear to be sufficient as the loci seem to be prone to instability in certain tumor types; immunophenotyping will not suffice either as cell lines of the same category will often have similar if not identical immunoprofiles. The presence of unique cytogenetic marker chromosomes or molecular biological analyses (eg identical clonal gene rearrangement patterns on Southern blots) might also provide unequivocal evidence for the derivation of the cell line from its patient. 74 
Cell line banks
It is advisable to obtain established cell lines from well-documented and quality-controlled sources such as established, non-profit culture collections rather than passed from one laboratory to another (a practice which also raised the mycoplasma problem to epidemic proportions). Naturally, it is important that cell lines be deposited with such culture collections by the original investigator.
Publications
It appears to be obvious that contributors to, as well as editors, referees and readers of scientific journals should attempt to avoid disseminating data based on inaccurately specified cell lines. 7 In any event, the source of cell lines used should be indicated in the Materials and methods section.
Good cell culture practice
We cannot overemphasize the need for scientists using cell lines to adhere to the strictest culture procedures possible and monitor, if possible, regularly for purity and identity. General preventive measures to lower the risk of cross-contamination go hand-in-hand with prevention of mycoplasma contamination. 75 
Awareness and vigilance
Awareness of the seriousness of the problem and continuous critical vigilance in this area might represent the most important steps to decrease the frequency of false cell lines 'floating throughout the scientific world' and to improve the current situation. The appearance of cells with phenotypic or other features different from those first noted in the primary cultures or in earlier passages is a characteristic occurrence in the course of cross-contamination of cultures and should ring an alarm bell. On the other hand, cross-contamination with a similar type of cell line may not necessarily lead to such a 'phenotypic/genotypic shift' in the cultured cells.
Summary
Cells cultured in vitro are a widely used and important resource in biomedical science. Their scientific relevance is definitely diminished when they are not properly and frequently monitored for identity and the expression of their unique characteristics. In working with such culture systems in a laboratory, it is important to know that inadvertent mixing of cultures can and does occur. The opportunities for crosscontamination of cell lines are legion. It is equally important to know that there are steps that may be taken (1) to prevent the risk of cross-contamination and (2) to establish the identity of cells grown in culture. The problem may be solved or at least mitigated by increasing the awareness of its seriousness and by introducing adequate identity control of cell lines. 9 Vigilance in this area is clearly needed to avoid recurrence of past errors and the resulting confusion and waste of time/money that they generate. 28, 76 
